Mechanisms of vasculitis: How pauci-immune is ANCA-associated renal vasculitis?

Nephron - Experimental Nephrology

Volumn 105, Issue 1, 2006, Pages

  Van Paassen, P ^a,c   Cohen Tervaert, J W ^a   Heeringa, P ^b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

ANCA associated renal vasculitis; Anti neutrophil cytoplasmic antibody; Glomerulonephritis; Neutrophil; Renal vasculitis; Vasculitis

Indexed keywords

NEUTROPHIL CYTOPLASMIC ANTIBODY;

ANTIBODY TITER; CELL INTERACTION; DATA ANALYSIS; DISEASE SEVERITY; ENDOTHELIUM CELL; GLOMERULONEPHRITIS; HISTOLOGY; HUMAN; IMMUNE RESPONSE; LEUKOCYTE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENOVASCULAR DISEASE; SHORT SURVEY; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE; VASCULITIS;

ANIMALS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; GLOMERULONEPHRITIS; HUMANS; INTERLEUKIN-18; MYELOBLASTIN; PEROXIDASE; RATS; RATS, INBRED BN; T-LYMPHOCYTES; VASCULITIS;

EID: 33845746405     PISSN: 16602129     EISSN: None     Source Type: Journal    
DOI: 10.1159/000096960     Document Type: Short Survey

References (44)

1. Falk RJ, Jennette JC: ANCA small-vessel vasculitis. J Am Soc Nephrol 1997;8:314-322.
2. Jennette JC: Antineutrophil cytoplasmic autoantibody-associated diseases: a pathologist's perspective. Am J Kidney Dis 1991;18:164-170.
3. Jennette JC: Rapidly progressive crescentic glomerulonephritis. Kidney Int 2003;63:1164-1177.
4. Kain R, Matsui K, Exner M, Binder S, Schaffner G, Sommer EM, Kerjaschki D: A novel class of autoantigens of anti-neutrophil cytoplasmic antibodies in necrotizing and crescentic glomerulonephritis: the lysosomal membrane glycoprotein h-lamp-2 in neutrophil granulocytes and a related membrane protein in glomerular endothelial cells. J Exp Med 1995;181:585-597.
5. Kallenberg CG, Brouwer E, Weening JJ, Tervaert JW: Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential. Kidney Int 1994;46:1-15.
6. Tervaert JW, Goldschmeding R, Elema JD, van der Giessen M, Huitema MG, van der Hem GK, The TH, dem Borne AE, Kallenberg CG: Autoantibodies against myeloid lysosomal enzymes in crescentic glomerulonephritis. Kidney Int 1990;37:799-806.
7. Tervaert JW, Huitema MG, Hene RJ, Sluiter WJ, The TH, van der Hem GK, Kallenberg CG: Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre. Lancet 1990;336:709-711.
8. Bansal PJ, Tobin MC: Neonatal microscopic polyangiitis secondary to transfer of maternal myeloperoxidase-antineutrophil cytoplasmic antibody resulting in neonatal pulmonary hemorrhage and renal involvement. Ann Allergy Asthma Immunol 2004;93:398-401.
9. Heeringa P, Huugen D, Tervaert JW: Antineutrophil cytoplasmic autoantibodies and leukocyte-endothelial interactions: a sticky connection? Trends Immunol 2005;26:561-564.
10. Jennette JC, Xiao H, Falk RJ: Pathogenesis of vascular inflammation by anti-neutrophil cytoplasmic antibodies. J Am Soc Nephrol 2006;17:1235-1242.
11. Rarok AA, Limburg PC, Kallenberg CG: Neutrophil-activating potential of antineutrophil cytoplasm autoantibodies. J Leukoc Biol 2003;74:3-15.
12. Charles LA, Caldas ML, Falk RJ, Terrell RS, Jennette JC: Antibodies against granule proteins activate neutrophils in vitro. J Leukoc Biol 1991;50:539-546.
13. Savage CO, Pottinger BE, Gaskin G, Pusey CD, Pearson JD: Autoantibodies developing to myeloperoxidase and proteinase 3 in systemic vasculitis stimulate neutrophil cytotoxicity toward cultured endothelial cells. Am J Pathol 1992;141:335-342.
14. 2 fragments is necessary but not sufficient to stimulate the recruitment of those downstream mediators used by intact ANCA IgG. J Am Soc Nephrol 2003;14:661-669.
15. Ben Smith A, Dove SK, Martin A, Wakelam MJ, Savage CO: Antineutrophil cytoplasm autoantibodies from patients with systemic vasculitis activate neutrophils through distinct signaling cascades: comparison with conventional Fc-γ receptor ligation. Blood 2001;98:1448-1455.
16. Kettritz R, Schreiber A, Luft FC, Haller H: Role of mitogen-activated protein kinases in activation of human neutrophils by antineutrophil cytoplasmic antibodies. J Am Soc Nephrol 2001;12:37-46.
17. Kettritz R, Choi M, Butt W, Rane M, Rolle S, Luft FC, Klein JB: Phosphatidylinositol 3-kinase controls antineutrophil cytoplasmic antibodies-induced respiratory burst in human neutrophils. J Am Soc Nephrol 2002;13:1740-1749.
18. Hewins P, Morgan MD, Holden N, Neil D, Williams JM, Savage CO, Harper L: IL-18 is upregulated in the kidney and primes neutrophil responsiveness in ANCA-associated vasculitis. Kidney Int 2006;69:605-615.
19. Reddy P: Interleukin-18: recent advances. Curr Opin Hematol 2004;11:405-410.
20. Moosig F, Csernok E, Kumanovics G, Gross WL: Opsonization of apoptotic neutrophils by anti-neutrophil cytoplasmic antibodies leads to enhanced uptake by macrophages and increased release of tumour necrosis factor-α. Clin Exp Immunol 2000;122:499-503.
21. Ewert BH, Becker ME, Jennette JC, Falk RJ: Antimyeloperoxidase antibodies induce neutrophil adherence to cultured human endothelial cells. Ren Fail 1995;17:125-133.
22. Haas M, Eustace JA: Immune complex deposits in ANCA-associated crescentic glomerulonephritis: a study of 126 cases. Kidney Int 2004;65:2145-2152.
23. Brouwer E, Huitema MG, Klok PA, de Weerd H, Tervaert JW, Weening JJ, Kallenberg CG: Antimyeloperoxidase-associated proliferative glomerulonephritis: an animal model. J Exp Med 1993;177:905-914.
24. Yang JJ, Jennette JC, Falk RJ: Immune complex glomerulonephritis is induced in rats immunized with heterologous myeloperoxidase. Clin Exp Immunol 1994;97:466-473.
25. Heeringa P, Brouwer E, Klok PA, Huitema MG, Van Den Born J, Weening JJ, Kallenberg CG: Autoantibodies to myeloperoxidase aggravate mild anti-glomerular-basementmembrane-mediated glomerular injury in the rat. Am J Pathol 1996;149:1695-1706.
26. Xiao H, Heeringa P, Hu P, Liu Z, Zhao M, Aratani Y, Maeda N, Falk RJ, Jennette JC: Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 2002;110:955-963.
27. Little MA, Smyth CL, Yadav R, Ambrose L, Cook HT, Nourshargh S, Pusey CD: Antineutrophil cytoplasm antibodies directed against myeloperoxidase augment leukocyte-microvascular interactions in vivo. Blood 2005;106:2050-2058.
28. Pfister H, Ollert M, Frohlich LF, Quintanilla-Martinez L, Colby TV, Specks U, Jenne DE: Antineutrophil cytoplasmic autoantibodies against the murine homolog of proteinase 3 (Wegener autoantigen) are pathogenic in vivo. Blood 2004;104:1411-1418.
29. Franssen CF, Stegeman CA, Kallenberg CG, Gans RO, De Jong PE, Hoorntje SJ, Tervaert JW: Antiproteinase 3- and antimyeloperoxidase-associated vasculitis. Kidney Int 2000;57:2195-2206.
30. Heeringa P, Van Den Born J, Brouwer E, Dolman KM, Klok PA, Huitema MG, Limburg PC, Bakker MA, Berden JH, Daha MR, Kallenberg CG: Elastase, but not proteinase 3 (Pr3), induces proteinuria associated with loss of glomerular basement membrane heparan sulphate after in vivo renal perfusion in rats. Clin Exp Immunol 1996;105:321-329.
31. Johnson RJ, Couser WG, Chi EY, Adler S, Klebanoff SJ: New mechanism for glomerular injury. Myeloperoxidase-hydrogen peroxide-halide system. J Clin Invest 1987;79:1379-1387.
32. Yang JJ, Preston GA, Pendergraft WF, Segelmark M, Heeringa P, Hogan SL, Jennette JC, Falk RJ: Internalization of proteinase 3 is concomitant with endothelial cell apoptosis and internalization of myeloperoxidase with generation of intracellular oxidants. Am J Pathol 2001;158:581-592.
33. Huugen D, Xiao H, van Esch A, Falk RJ, Peutz-Kootstra CJ, Buurman WA, Tervaert JW, Jennette JC, Heeringa P: Aggravation of antimyeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide: role of tumor necrosis factor-α. Am J Pathol 2005;167:47-58.
34. Xiao H, Heeringa P, Liu Z, Huugen D, Hu P, Maeda N, Falk RJ, Jennette JC: The role of neutrophils in the induction of glomerulonephritis by antimyeloperoxidase antibodies. Am J Pathol 2005;167:39-45.
35. Lamprecht P: Off balance: T-cells in antineutrophil cytoplasmic antibody-associated vasculitides. Clin Exp Immunol 2005;141:201-210.
36. Gutfleisch J, Baumert E, Wolff-Vorbeck G, Schlesier M, Strutz HJ, Peter HH: Increased expression of CD25 and adhesion molecules on peripheral blood lymphocytes of patients with Wegener's granulomatosis and ANCA-positive vasculitides. Adv Exp Med Biol 1993;336:397-404.
37. + T cells exhibiting an unbalanced Th1-type T cell cytokine pattern: reversal with IL-10. J Immunol 1998;160:3602-3609.
38. Moosig F, Csernok E, Wang G, Gross WL: Costimulatory molecules in Wegener's granulomatosis: lack of expression of CD28 and preferential up-regulation of its ligands B7-1 (CD80) and B7-2 (CD86) on T cells. Clin Exp Immunol 1998;114:113-118.
39. - T cells are a major source of interferon-γ and tumor necrosis factor-α in Wegener's granulomatosis. Am J Pathol 2002;160:1717-1724.
40. Lamprecht P, Moosig F, Csernok E, Seitzer U, Schnabel A, Mueller A, Gross WL: CD28-negative T cells are enriched in granulomatous lesions of the respiratory tract in Wegener's granulomatosis. Thorax 2001;56:751-757.
41. Brouwer E, Stegeman CA, Huitema MG, Limburg PC, Kallenberg CG: T-cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis. Clin Exp Immunol 1994;98:448-453.
42. Griffith ME, Coulthart A, Pusey CD: T cell responses to myeloperoxidase and proteinase 3 in patients with systemic vasculitis. Clin Exp Immunol 1996;103:253-258.
43. Lawyer C, Henkle J, Bakir H: Nasal carriage of staphylococcal infection in Wegener granulomatosis. Ann Intern Med 1994;121:74-75.
44. + T lymphocytes in response to Staphylococcus aureus in patients with Wegener's granulomatosis. Scand J Immunol 1999;49:585-594.